Avalo Therapeutics, Inc. · NASDAQ:AVTX
Logos Global Management LP's stake in Avalo Therapeutics, Inc. fell to 3.20% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Logos Global Management LP's stake in Avalo Therapeutics, Inc. fell to 3.20%, 1,675,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 3.20%
- Shares
- 1,675,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Logos Global Management LP | 3.20% | 1,675,000 |
| Logos Global Management GP LLC | 3.20% | 1,675,000 |
| Logos Global Master Fund LP | 3.20% | 1,675,000 |
| Logos GP LLC | 3.20% | 1,675,000 |
| Arsani William | 3.20% | 1,675,000 |
Source
Related
- Avalo Therapeutics, Inc.
- Logos Global Management LP
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G · Logos Global Management LP · Apr 1, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026